Salbutamol Tablets: Uses, Dosage, and Safety
Salbutamol tablets, also known as albuterol tablets, are a commonly prescribed medication for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). As a bronchodilator, salbutamol tablets help to alleviate symptoms of airway constriction and improve breathing. This comprehensive guide aims to provide a detailed understanding of salbutamol tablets, including their uses, dosage, side effects, and safety considerations. Whether you’re a patient or a healthcare professional, this guide will equip you with the knowledge needed to make informed decisions regarding salbutamol tablet therapy.
Understanding Respiratory Conditions
1.1 Asthma: Causes, Symptoms, and Triggers
1.2 Chronic Obstructive Pulmonary Disease (COPD): Types and Risk Factors
1.3 Role of Bronchodilators in Managing Respiratory Conditions
Introduction to Salbutamol Tablets
2.1 What are Salbutamol Tablets?
2.2 Mechanism of Action
2.3 Available Brands and Forms of Salbutamol Tablets
Medical Uses of Salbutamol Tablets
3.1 Treatment and Management of Asthma
3.2 Management of Chronic Obstructive Pulmonary Disease (COPD)
3.3 Off-Label Uses of Salbutamol Tablets
Dosage and Administration
4.1 Recommended Dosage for Different Age Groups
4.2 Dosage Forms and Strengths of Salbutamol Tablets
4.3 Administration Techniques and Instructions
4.4 Monitoring and Adjusting Dosage
Potential Side Effects and Precautions
5.1 Common Side Effects of Salbutamol Tablets
5.2 Rare but Serious Side Effects
5.3 Allergic Reactions and Anaphylaxis
5.4 Precautions and Contraindications
5.5 Drug Interactions with Salbutamol Tablets
Safety Considerations and Special Populations
6.1 Safety Guidelines for Pregnant and Breastfeeding Women
6.2 Use of Salbutamol Tablets in Pediatric Patients
6.3 Geriatric Considerations and Dosage Adjustments
6.4 Managing Salbutamol Tablets in Patients with Comorbidities
Monitoring and Management
7.1 Regular Check-ups and Lung Function Tests
7.2 Assessing Treatment Response and Adjusting Therapy
7.3 Inhaler Technique and Patient Education
Lifestyle Considerations and Self-Care
8.1 Asthma Action Plans and Self-Monitoring
8.2 Environmental Triggers and Asthma Control
8.3 Healthy Lifestyle Habits for Respiratory Health
Frequently Asked Questions about Salbutamol Tablets
9.1 Can Salbutamol Tablets Cure Asthma or COPD?
9.2 How Long Can Salbutamol Tablets Be Used?
9.3 Are Salbutamol Tablets Safe for Long-Term Use?
9.4 Can Salbutamol Tablets Be Used as a Rescue Medication?
Emerging Trends and Future Directions
10.1 Novel Formulations and Delivery Systems
10.2 Personalized Medicine Approaches
10.3 Advances in Monitoring and Telemedicine
Salbutamol tablets are an essential medication in the management of respiratory conditions such as asthma and COPD. By understanding their uses, dosage, potential side effects, and safety considerations, patients and healthcare professionals can make informed decisions regarding their therapy. It is crucial to follow the recommended dosage and administration instructions, monitor treatment response, and be aware of potential interactions or precautions. Regular communication with healthcare providers and adherence to an overall management plan can help individuals effectively control their respiratory symptoms and improve their quality of life. With this comprehensive guide, you are equipped with the knowledge needed to navigate the world of salbutamol tablets confidently.
MASTER FORMULA OF SALBUTAMOL TABLET
PURPOSE: This Master Formula is written to describe the formulae, manufacturing procedure, specifications, packing details of dosage form.
SCOPE: This MFR is performed and is applied during the manufacturing of dosage form.
RESPONSIBILITY / ACCOUNTABILITY: It is the responsibility of Manufacturing Chemist to follow and adhere to this SOP. The Production Pharmacist, QC/QA Manager are accountable for the strict adherence to the master formula.
COPY ISSUED TO:
1. Master Copy: Manager Quality Assurance
2. Copy No. 1: Production Pharmacist
3. Copy No. 2: Manager Quality Control
4. Copy No. 3: Tablet Section
|PRODUCT NAME: SALBUTAMOL TABLET||BATCH SIZE: 5.0 LAC|
|PRODUCT REFERENCE CODE:||UNIT SIZE: 2 X 50|
|GENERIC NAME: SALBUTAMOL SULPHATE B.P.||PACK SIZE: 20 X 10 X 2 X 50|
|DOSAGE FORM: TABLET||STRENGTH: N.A.|
|DEPARTMENT: TABLET DEPARTMENT||EXPIRY DATE: AFTER 36 MONTHS FROM THE DATE OF MANUFACTURING|
Each Uncoated Tablet contains:
Salbutamol Sulphate B.P.
Equivalent to Salbutamol 4 mg
SPECIMEN OF LABEL :
EQUIPMENTS TO BE USED:
|SR. NO.||NAME OF EQUIPMENT||ASSEMBLING
AS PER SOP NO.
AS PER SOP NO.
|1||Steam Jacketed Starch Paste Preparation Tank|
|2||Sifter Machine – I|
|3||Roto Cube Blender –I|
|4||Rapid Mixer Granulator|
|6||Fluidized Bed Drier|
|8||Sifter Machine – II|
|9||Roto Cube Blender – II|
|10||Tablet Compression Machine 27 Stations|
|12||Tablet Inspection Machine|
|13.||Triple Track Blister Machine|
|S.NO.||INGREDIENTS||STD||Theoretical Quantity Req.||Overages %||Total Quantity Used|
|2.||DI CALCIUM PHOSPHATE||B.P.||20.000||20.000 KG|
|3.||ERYTHROCIN COLOUR||F.G.||25.000||25.000 Gm|
|5||MAGNESIUM STERATE||B.P.||0.500||0.500 KG|
|6||SALBUTAMOL SULPHATE||B.P.||2.480||5%||2.604 KG|
|7||SODIUM BENZOATE||B.P.||0.500||0.500 KG|
|S.NO.||NAME OF THE MATERIAL||Theoretical Quantity Req.||For
|Total Quantity Used|
|1.||185 MM CLEAR PVC||50.000||50.000 KG|
|2.||ADHESIVE TAPE ROLL BROWN||1.00||1.00 KGS|
|3.||UNIT CARTON||5000.000||2.00||5002.000 NOS|
|4||OUTER CARTON||500.000||2.00||502.00 NOS|
|5||CELLO TAPE||5.000||5.000 NOS|
|6||CORRUGATED BOX T – 10||5.000||5.000 NOS|
Moisture content of powder should be less than 2.0 %.
Average weight of each Tablet is 220 milligrams.
Weight Variation Limit for average weight of 20 tablets is + 7.5 %.
Friability limit for 20 Tablets is not more than 1.0 %.
Hardness of the Tablets varies between 2 – 4 kg/cm2.
Disintegration time for each Tablet is not more than 15 minutes.
Mix the batch, compress and de-dust the tablets and also perform the primary packing of Tablets at temperature not more than 25˚C.
Theoretical Yield is 5.0 Lacs Tablets.
Expected Practical Yield is 5.0 Lacs + 2% Tablets
Use PVC 185 mm transparent and Aluminum foil for blister packing.
Blister Pack the inspected and De-dusted tablets by using Triple Track Blister Packing Machine as per its SOP.
Put 2 strips each containing 50 tablets in each inner carton.
Put such 10 inner cartons in one outer carton.
Seal each outer carton from both ends with cello tape.
Pack 20 outer cartons in specified corrugated box T-10 to give a pack size of 20 x 10 x 2 x 50 tablets.
Seal the each corrugated box with adhesive tape and label it properly by affixing the specified label.
Preparation of Starch Paste:
Prepare the starch paste in the manner given below using Steam Jacketed Starch Paste Preparation Tank by operating it as per its SOP.
Dissolve 0.5 kg of Sodium Benzoate in 2 Ltrs of DM water and stir continuously.
Add 2.0 kg of Starch in 3.0 Ltrs DM water and make slurry stir continuously.
Heat 20 Ltrs of DM water separately.
Dissolve 25g of Erythrocin colour in 1Ltr of boiling water and add to the above solution.
To this add the solution of sodium benzoate and starch slurry with constant stirring to get a uniform paste.
Sifting: Fit Stainless Steel Sieve # 20 on the Sifter-I as per its SOP. Sift all the ingredients through it and collect separately in Stainless Steel Container.
Blending: Add the following ingredients in a Roto Cube Blender-I and start blending for 30 minutes by operating it as per its SOP. Collect the blended powder in Stainless Steel Containers.
20.0 kg of Di-Calcium Phosphate
10.0 kg of Lactose
2.604 kg of Salbutamol Sulphate
42.5 kg of Starch
Wet Granulation: Mix the above blended ingredients with the Starch paste using Rapid Mixer Granulator by operating it as per its SOP. Add starch paste to the blended powder in a manner to achieve proper wetting by following the procedure given below:
Divide the blended powder in two equal parts.
Divide the prepared starch paste in two equal parts.
Mix one part of the blended powder and starch paste together in Rapid Mixer Granulator.
Similarly mix the next part in the same manner.
Wet Screening: Pass the wet dough through a Multi Mill by operating it as per its SOP to convert the moist mass into coarse, granular aggregates.
Drying: Dry the granules in Fluidized Bed Drier by operating it as per its SOP at temperature 60˚ – 70˚ C for 30 minutes. Cool the granules to room temperature.
Sifting: Fit Stainless Steel Sieve # 20 on the Sifter-II as per its SOP. Sift the dried granules through it and collect in Stainless Steel Container. Break the oversized granules left over the mesh in Oscillating Granulator by operating it as per its SOP and resift them.
Check the total weight of dried granules. Determine the loss on drying and percentage yield of dried granules.
Lubrication: Lubricate the sifted granules along the following ingredients in Roto Cube Blender by operating it as per its SOP. Mix all the ingredients for 15minutes and collect in Stainless Steel Container.
0.150 kg of Aerosil
0.500 kg of Magnesium Stearate
6.0 kg of Starch
1.0 kg of Talcum
Send the granules for bulk testing to Quality Control Department for assay of Active Ingredients.
Compression: Shift all the granules for compression to Tablet Compression Machine 27 Stations by operating it as per its SOP and collect the compressed tablets in Stainless Steel Container.
Tablet Inspection: Transfer the compressed tablets to the Tablet Inspection Machine and sort out the defected tablets by operating it as per its SOP and collect the selected tablets in separate labelled Stainless Steel Containers.
Loose Packing: Shift the inspected tablets for Loose Packing.
The following in-process controls should be maintained during the processing:
Check Raw materials used for manufacturing purpose are all approved materials and have ‘Released’ labels fixed on it.
All weighed Raw materials should be counter-checked by Manufacturing Chemist. If any discrepancy is noticed, it should be immediately brought to the notice of Production Pharmacist and QC/QA Manager.
Physical characteristics of Raw material like colour, odour, and consistency are checked before compounding.
Humidity and temperature should be maintained during the compression of thermolabile products.
Sample of dried granules should be sent to Quality Control Department for the determination of Moisture content.
The total weight of blended powder should be checked in the presence of Manufacturing Chemist and record the same in Batch Manufacturing Record.
Bulk sample should be sent for analysis to Quality Control Department before starting compression of tablets.
Weight Variation: I) Intermittently weight variation of compressed tablets should be checked at 30 minutes interval by the Assistant Manufacturing Chemist and record for the same should be kept in Batch Manufacturing Record
II) Out-of-limit tablets should be checked by Weight Variation Method as given below:
i) Take the average weight of 20 tablets on the calibrated balance and calculate the upper and lower limit as per the table given below in accordance with IP/BP:
|AVERAGE WEIGHT OF TABLETS (in mg)||MAXIMUM PERCENTAGE DIFFERENCE ALLOWED|
|80mg or less||10|
|More than 80mg and less than 250 mg||7.5|
|250mg or more||5|
Take the weight of individual tablets and checks if all the tablets are lying with in the limits.
Select the tablets only if no more than two tablets are out of percentage limit and if no tablet differs by more than two times the percentage limit, otherwise reject the tablets.
Adjust the desired weight of the tablets in the Compression Machine by moving weight adjustment cam clockwise or anticlockwise accordingly as per the Standard Operating Procedure of Compression Machine.
Re-check the weight of tablets for further adjustment, if any.
Thickness of Tablets: Thickness of the tablets should be determined by means of the vernier caliper. The thickness of the tablet should be checked whenever weight adjustments are made.
Hardness of the tablets: The equipment used is the ‘Monsanto’ type hardness tester. Hardness of the compressed tablets should be checked at regular interval to determine the need for pressure adjustments on the tableting machine.
Hardness of tablets varies between: 2-4 Kg/cm2.
Roche Friabilator is used for measuring the Friability. The instrument is designed to evaluate the ability of the tablet to withstand abrasion in packaging, handling and shipping.
Adjust the instrument to 25 RPM before adding the tablets.
Weigh 20 Tablets on calibrated balance. Transfer the tablets in the plastic chamber. Close the drum tightly.
Switch on the apparatus. Operate the Friabilator for 100 revolutions.
De-dust and reweigh the tablets. Loss in weight indicates the ability of tablets to withstand the wear.
Take 10 tablets to check the friability, when the average weight of tablet is 1g or more than 1g.
Friability Limit = Less than 1.0%
Disintegration is the time required for the group of tablets to disintegrate into the particles. Disintegration Test should be carried out at regular interval of 1 hour by using Disintegration Test Apparatus.
The tube assembly unit is removed from the glass beaker and from each tube the plastic discs are removed.
Place the tablets in each of 6 tubes along with a plastic disc over the tablets.
The glass beaker is filled with water. The water in the beaker is retained at the temperature of 37+1˚C through out the test by suitably setting the thermostat.
Introduce a tube assembly unit into glass beaker in such a way that wire mesh at the base of each tube is at least 2.5cm below the surface of liquid when the basket is at highest position.
Switch on the apparatus to move the basket assembly containing the tablets up and down through a distance of 5 to 6 cm at a frequency of 28 to 32 cycles per minute. Start the stopwatch.
When the tablets have disintegrated i.e. when no particles remain on the wire mesh at the bottom of tube, stop the stopwatch. Note the time taken for disintegration of the tablets and record the same in Batch Manufacturing Record.
If one or two tablets fail to disintegrate, the test is to be repeated using 12 tablets
Disintegration Time of uncoated tablets= Not more than 15 minutes
Disintegration Time of coated tablets= Not more than 30 minutes
Tablets taken for testing and In-process control should not be added to the bulk batch to avoid mix-ups and cross-contamination.
Inspection, sorting of rejected tablets should be done as per SOP.
The strips and cartons should be checked thoroughly for proper batch coding.
Manufacturing Chemist and Production should randomly check that the correct no. of strips are being packed in each cartons and also the number of cartons in each shipper is exactly the same as that shown in proof.
Intimation should be sent to Quality Control Department for finished product sampling and testing.
After the completion of labelling and packaging, the coded cartons should be accounted for and rejected printed material should be destroyed in the presence of QC/QA Manager. Fill the destruction sheet and attach the same in the Batch Manufacturing Record.
It will be ensure that filling or packaging equipment has been properly cleaned after the completion of batch.
Filling or packaging of next product should not commence until the IPQA has given the ‘Line Clearance’
OTHER RELATED POST- MASTER FORMULA OF ALBENDAZOLE TABLETS